Essential Asia

Are Institutions Funding AI Abundance or Catastrophe?

Every dollar backing the AI buildout is a wager that AI will deliver extraordinary gains rather than disaster. Asset owners are in on that bet, whether they realize it or not.

北京环球投资论坛 2026 Beijing Global Investment Forum 2026

November 5, 2026 | Beijing

Gulf Credit Is More Liquid Than You Think

Electronic trading and rising turnover are helping make Gulf credit more liquid than its reputation suggests.

AI Drug Discovery Reaches the IPO Market

Iambic Therapeutics, backed by Coatue, Nvidia, Millennium, and Two Sigma, is bringing its AI-based drug development to public investors.

SPONSORED

Why Asia and Europe Are Turning to U.S. Crude Oil

Related Content

Opinion: The AI Diligence Question Every Asset Owner Should Be Asking

Angelo Calvello

AI Meets Biotech — and Hedge Funds Are Buying In

Stephen Taub

The Art — and Imperfection — of Due Diligence

Christopher Schelling

Alpha Edge Asia 2026

October 21, 2026 | Island Shangri-La

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X
Bluesky
Instagram